©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 28, 2014; 20(24): 7730-7738
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7730
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7730
Stretta: A valuable endoscopic treatment modality for gastroesophageal reflux disease
George Triadafilopoulos, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, United States
Author contributions: Triadafilopoulos G contributed solely to this manuscript.
Correspondence to: George Triadafilopoulos, MD, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, M-211, Stanford, CA 94305, United States. vagt@stanford.edu
Telephone: +1-650-9887488 Fax: +1-650-9887486
Received: August 5, 2013
Revised: December 14, 2013
Accepted: March 6, 2014
Published online: June 28, 2014
Processing time: 326 Days and 3.9 Hours
Revised: December 14, 2013
Accepted: March 6, 2014
Published online: June 28, 2014
Processing time: 326 Days and 3.9 Hours
Core Tip
Core tip: Stretta may serve as an endoscopic pain modulator and should be considered in patients with refractory symptoms despite proton pump inhibitors, as well as in patients with functional heartburn.